Comparison of Fixed-dose Combinations of Amlodipine/Losartan potassium (cas 12475-99-8)/Chlorthalidone and Amlodipine/Losartan potassium (cas 12475-99-8) in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan potassium (cas 12475-99-8): A Randomized, Double-blind, Multicenter, Phase III Study
-
Add time:08/11/2019 Source:sciencedirect.com
PurposeThe goal of this study was to compare the efficacy and safety of fixed-dose combinations of amlodipine/losartan potassium/chlorthalidone (A/L/C) and A/L in Korean patients with stage 2 hypertension inadequately controlled by A/L.
We also recommend Trading Suppliers and Manufacturers of Losartan potassium (cas 12475-99-8). Pls Click Website Link as below: cas 12475-99-8 suppliers
Prev:Modulating effect of Losartan potassium (cas 12475-99-8) on the mutagenicity and recombinogenicity of doxorubicin in somatic cells of Drosophila melanogaster
Next:Design and evaluation of controlled release Losartan potassium (cas 12475-99-8) microcapsules) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Molecular insight into atypical instability behavior of fixed-dose combination containing amlodipine besylate and Losartan potassium (cas 12475-99-8)08/19/2019
- Formulation and evaluation of sublingual tablets of Losartan potassium (cas 12475-99-8)08/18/2019
- A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium (cas 12475-99-8) by 32 factorial design approach08/17/2019
- A clean photometric method for the determination of Losartan potassium (cas 12475-99-8) in pharmaceuticals exploiting light scattering effect and employing a multicommuted flow analysis approach08/16/2019
- Computational study of influence of diffuse basis functions on geometry optimization and spectroscopic properties of Losartan potassium (cas 12475-99-8)08/15/2019
- Significance of Metabolites in Bioequivalence: Losartan potassium (cas 12475-99-8) as a Case Study08/14/2019
- Utilizing Guar Gum for Development of “Tabs In Cap’ System of Losartan potassium (cas 12475-99-8) for Chronotherapeutics08/13/2019
- Design and evaluation of controlled release Losartan potassium (cas 12475-99-8) microcapsules08/12/2019
- Modulating effect of Losartan potassium (cas 12475-99-8) on the mutagenicity and recombinogenicity of doxorubicin in somatic cells of Drosophila melanogaster08/10/2019
-
Health and Chemical more >
-
Related Products
- Losartan carboxylic acid
- Losartan potassium
- Potassium (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylate
- Potassium (4-formylphenyl)trifluoroborate
- Potassium (bromomethyl)trifluoroborate
- Potassium (R)-((3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino)(4-hydroxyphenyl)acetate
- Potassium (R)-(4-hydroxyphenyl)((3-methoxy-1-methyl-3-oxoprop-1-enyl)amino)acetate
- Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
- Potassium [(cyanomethyl)thio]acetate
- Potassium 1,2,3,6-tetrahydro-5-nitro-2,6-dioxopyrimidine-4-carboxylate


